Logo (Elelyso 01)
Elelyso Injection, Powder, Lyophilized, For Solution
Product Images NDC 0069-0106
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Elelyso (NDC 0069-0106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (200 Unit Vial Label)
Label for Elelyso (taliglucerase alfa) injection, lyophilized powder for solution. Strength indicated is 200 units per vial for intravenous infusion. Label includes storage instructions (2° to 8°C), light protection warning, lot number, and manufacturer details: Pfizer Laboratories Division of Pfizer Inc, New York, NY. The product is marked as prescription only with a single-dose vial usage note.*
Principal Display Panel (200 Unit Vial Carton)
Carton label for Elelyso (taliglucerase alfa) injection, lyophilized powder for solution, 200 units per vial. The label includes dosing instructions, storage guidelines (2°C to 8°C, protect from light), and manufacturer information (Pfizer Inc.). The product is indicated for intravenous infusion and packaged as a single-dose vial. Anti-counterfeit and barcode markings are visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
